Lilly(Eli) & Co (LLY) concluded trading on Thursday at a closing price of $786.23, with 3.94 million shares of worth about $3.09 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.96% during that period and on November 14, 2024 the price saw a loss of about -3.15%. Currently the company’s common shares owned by public are about 949.38M shares, out of which, 850.73M shares are available for trading.
Stock saw a price change of -1.41% in past 5 days and over the past one month there was a price change of -14.21%. Year-to-date (YTD), LLY shares are showing a performance of 34.88% which increased to 28.72% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $561.65 but also hit the highest price of $972.53 during that period. The average intraday trading volume for Lilly(Eli) & Co shares is 3.15 million. The stock is currently trading -7.40% below its 20-day simple moving average (SMA20), while that difference is down -11.23% for SMA50 and it goes to -5.79% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lilly(Eli) & Co (NYSE: LLY) currently have 949.38M outstanding shares and institutions hold larger chunk of about 72.70% of that.
The stock has a current market capitalization of $746.38B and its 3Y-monthly beta is at 0.42. PE ratio of stock for trailing 12 months is 86.01, while it has posted earnings per share of $9.14 in the same period. Its PEG reads 2.54 and has Quick Ratio of 0.97 while making debt-to-equity ratio of 2.19. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LLY, volatility over the week remained 3.29% while standing at 2.84% over the month.
Stock’s fiscal year EPS is expected to rise by 109.82% while it is estimated to increase by 69.35% in next year. EPS is likely to grow at an annualized rate of 33.80% for next 5-years, compared to annual growth of 13.74% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Bernstein on October 17, 2024 offering an Outperform rating for the stock and assigned a target price of $1100 to it. Coverage by Citigroup stated Lilly(Eli) & Co (LLY) stock as a Buy in their note to investors on September 13, 2024, suggesting a price target of $1060 for the stock. On August 12, 2024, Deutsche Bank Upgrade their recommendations, while on February 21, 2024, DZ Bank Downgrade their ratings for the stock with a price target of $820. Stock get an Overweight rating from Morgan Stanley on February 16, 2024.
